Clinical Trials - October 29, 2014
New study planned for Diamyd’s diabetes vaccine
In order to increase the scientific value of the research on preventative treatment with the Diamyd® diabetes vaccine, the research team at Lund University, who have been driving the DiAPREV-IT study since 2009, decided to expand the dataset with additional children at high risk of presenting with type 1 diabetes. Therefore, after discussions with the […]
Drug Development Pharma - April 4, 2014
Diamyd to open cord blood bank
The company will invest SEK 11.5 million for the establishment of a commercial cord blood bank in Sweden for private family saving of umbilical cord blood and other sources of stem cells.
Drug Development Pharma - February 27, 2013
Diamyd’s shareholders in agreement
Shareholders in Diamyd Medical AB representing a majority of the votes in the company have reached an agreement to distribute the parent company’s excess cash to the shareholders and to convert all shares to series B shares with equal voting power. The shares in the subsidiary Diamyd Therapeutics AB shall be distributed to the shareholders […]
